7/28/2015
Google Plus Profile LinkedIn Profile Check us out on YouTube

Market Research

Bill Kelly / 5/5/2015 / 0 Comments

Scientists Support Moratorium on Human Germline Genome Editing

We’re just a few weeks away from publishing our report on the fast growing market for CRISPR/Cas9 products. In the meantime, we've also been engaging with scientists on the ethical questions surround this exciting technology. Before the recent announcement from China that CRISPR had been used to modify ...

Market Research

Bill Kelly / 4/24/2015 / 0 Comments

CRISPR/Cas9 - What's Next for Life Science Suppliers?

Thumbnail for CRISPR/Cas9 - What's Next for Life Science Suppliers?

Few in our industry would disagree with MIT’s Technology Review characterization of CRISPR/Cas9 as “the biggest biotech discovery of the century.” And yesterday’s revelation that Chinese scientists have already edited the genomes of human embryos has touched off yet another ethical debate as well as warnings that the ...

Market Research

Zach French / 4/17/2015 / 0 Comments

By the Numbers: The Stem Cell Research Products Market

In March 2015, BioInformatics released the third title on its cloud-based analytics platform, Interactive Market Intelligence. The Market for Stem Cell Research Products, a quantitative and primary research analysis, is now accessible online. Here’s what you can expect to learn: The market size, share and growth by region, industry segment and product ...

Market Research

Bill Kelly / 4/9/2015 / 0 Comments

Welcome back – make yourself comfortable and stay awhile!

When we first started in the market research business we viewed ourselves primarily as a publisher of market research. We developed our off-the-shelf reports largely from quantitative surveys of scientific customers rather than from secondary sources as others were doing. Twenty years ago we were using postal mail ...

Who We Are

BioInformatics LLC provides data-driven insights to leading companies servicing the life science, medical device, and pharmaceutical industries.

Learn more at www.gene2drug.com